PARIHEP 40MG INJECTION 0.4 ML
By ABBOTT HEALTH CARE PRIVATE LIMITED
Contains: ENOXAPARIN 40 MG
Product Summary
| Offer Price | ₹ 342 |
|---|---|
| Your Savings | ₹ 85.79 (20% on MRP) |
About PARIHEP 40MG INJECTION 0.4 ML
- PARIHEP 40MG INJECTION 0.4 ML is an anticoagulant medication that belongs to the class of low molecular weight heparins (LMWHs). It is derived from unfractionated heparin and is used to prevent and treat blood clots. PARIHEP 40MG INJECTION 0.4 ML works by inhibiting the formation of blood clots and preventing existing clots from growing larger. It is administered via subcutaneous injection and is commonly prescribed for conditions such as deep vein thrombosis, pulmonary embolism, and to prevent blood clotting during certain surgical procedures.
Uses of PARIHEP 40MG INJECTION 0.4 ML
- Helps in preventing blood clots
- Used in deep vein thrombosis
- Helps in treating pulmonary embolism
- Used for clot prevention during surgery
- Helps in unstable angina
- Used in non-Q wave myocardial infarction
- Helps in preventing blood clot formation in certain medical conditions
- Used for acute ST-segment elevation myocardial infarction
How PARIHEP 40MG INJECTION 0.4 ML Works
- PARIHEP 40MG INJECTION 0.4 ML works by inhibiting the activity of specific clotting factors, preventing the formation and growth of blood clots.
- PARIHEP 40MG INJECTION 0.4 ML works by binding to antithrombin III, a natural protein in the body. This complex then inhibits specific clotting factors, such as factor Xa and thrombin, which are involved in the formation of blood clots. By inhibiting these clotting factors, PARIHEP 40MG INJECTION 0.4 ML helps prevent the formation of new blood clots and stops existing clots from growing larger. PARIHEP 40MG INJECTION 0.4 ML primarily acts on the coagulation pathway, specifically the intrinsic pathway, and has a greater effect on factor Xa compared to thrombin. By selectively targeting factor Xa, PARIHEP 40MG INJECTION 0.4 ML provides anticoagulant effects while minimizing the risk of bleeding complications associated with other clotting factors. The medication is administered via subcutaneous injection, allowing for convenient absorption into the bloodstream. The duration and dosage of PARIHEP 40MG INJECTION 0.4 ML depend on the specific medical condition being treated and the individual patient's characteristics, such as body weight. It is important to follow the prescribed dosage and duration of treatment to ensure optimal efficacy and minimize the risk of side effects.
Dosage of PARIHEP 40MG INJECTION 0.4 ML Works
- Dosage for children: The dosage of PARIHEP 40MG INJECTION 0.4 ML for children depends on their body weight and the specific medical condition being treated. It is determined by the healthcare provider and administered via subcutaneous injection.
- Dosage for Adults: The dosage of PARIHEP 40MG INJECTION 0.4 ML for adults varies depending on the medical condition being treated. It is typically administered as a fixed dose or based on body weight and is given via subcutaneous injection.
Side Effects Of PARIHEP 40MG INJECTION 0.4 ML
- Bleeding
- Bruising
- Injection site reaction
- Anemia
- Low platelet count
How to Store PARIHEP 40MG INJECTION 0.4 ML
- Store at room temperature (between 20°C and 25°C)
- Protect from light
- Keep out of reach of children
Frequently asked questions about PARIHEP 40MG INJECTION 0.4 ML
PARIHEP 40MG INJECTION 0.4 ML is used to prevent and treat blood clots in conditions such as deep vein thrombosis, pulmonary embolism, and during certain surgical procedures.
PARIHEP 40MG INJECTION 0.4 ML is administered via subcutaneous injection, typically into the fatty tissue of the abdomen or thigh.
Common side effects of PARIHEP 40MG INJECTION 0.4 ML include bleeding, bruising, injection site reactions, anemia, and low platelet count.
PARIHEP 40MG INJECTION 0.4 ML should only be used during pregnancy if the potential benefits outweigh the potential risks. It is important to consult with a healthcare provider.
PARIHEP 40MG INJECTION 0.4 ML can be used in elderly patients, but caution should be exercised due to the increased risk of bleeding associated with age-related factors. Close monitoring is essential.
PARIHEP 40MG INJECTION 0.4 ML can be used in individuals with liver or kidney disease, but dose adjustments may be necessary. It is important to consult with a healthcare provider.
If you miss a dose of PARIHEP 40MG INJECTION 0.4 ML, contact your healthcare provider for instructions. Do not double the dose to make up for the missed one.
PARIHEP 40MG INJECTION 0.4 ML may interact with certain medications, including other anticoagulants and antiplatelet drugs. Inform your healthcare provider about all medications you are taking.
References related to PARIHEP 40MG INJECTION 0.4 ML
- CDSCO. (2023). Retrieved June 9, 2023, from Cdscoonline.gov.in website: https://cdscoonline.gov.in/CDSCO/Drugs
bhavtosh vyas
Reviewed on 31 Jan 2024
bhavtosh vyas
Reviewed on 31 Jan 2024
वेरी गुड एक्सीलेंट
Shraddha Landge
Reviewed on 23 Jan 2024
Shraddha Landge
Reviewed on 23 Jan 2024
It's good work and always best treatment and every time attend coustomer properly and perfectly
monalisha satapathy
Reviewed on 05 Aug 2023
monalisha satapathy
Reviewed on 05 Aug 2023
Genuine products
Neha Pathak
Reviewed on 10 Feb 2024
Neha Pathak
Reviewed on 10 Feb 2024
Can get the medicines here on pocket friendly rates !
Akanksha Gupta
Show More
Reviewed on 20 Oct 2023
Akanksha Gupta
Reviewed on 20 Oct 2023
(Translated by Google) My experience is very good discount, if you want to give extra medicine, retu Show More